20 Microns [20MICRONS] vs Chemo-Pharma [CPL] Detailed Stock Comparison

20 Microns Ltd.

NSE
Loading...

Chemo-Pharma Laboratories Inc.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: 20 Microns Ltd. wins in 11 metrics, Chemo-Pharma Laboratories Inc. wins in 8 metrics, with 0 ties. 20 Microns Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric 20 Microns Ltd. Chemo-Pharma Laboratories Inc. Better
P/E Ratio (TTM) 9.76 13.22 20 Microns Ltd.
Price-to-Book Ratio 1.39 2.69 20 Microns Ltd.
Debt-to-Equity Ratio 35.64 48.02 20 Microns Ltd.
PEG Ratio 0.60 0.42 Chemo-Pharma Laboratories Inc.
EV/EBITDA 6.29 13.60 20 Microns Ltd.
Profit Margin (TTM) 7.00% 6.53% 20 Microns Ltd.
Operating Margin (TTM) 10.62% 11.52% Chemo-Pharma Laboratories Inc.
EBITDA Margin (TTM) 10.62% 11.52% Chemo-Pharma Laboratories Inc.
Return on Equity 14.37% 20.97% Chemo-Pharma Laboratories Inc.
Return on Assets (TTM) 8.73% 11.26% Chemo-Pharma Laboratories Inc.
Free Cash Flow (TTM) $-448.94M $41.66M Chemo-Pharma Laboratories Inc.
Dividend Yield 0.45% N/A N/A
1-Year Return -18.83% -5.34% Chemo-Pharma Laboratories Inc.
Price-to-Sales Ratio (TTM) 0.68 1.31 20 Microns Ltd.
Enterprise Value $7.38B $5.40B 20 Microns Ltd.
EV/Revenue Ratio 0.80 1.52 20 Microns Ltd.
Gross Profit Margin (TTM) 45.73% 24.93% 20 Microns Ltd.
Revenue per Share (TTM) $261 $62 20 Microns Ltd.
Earnings per Share (Diluted) $18.28 $5.81 20 Microns Ltd.
Beta (Stock Volatility) 0.55 0.28 Chemo-Pharma Laboratories Inc.

20 Microns Ltd. vs Chemo-Pharma Laboratories Inc. Stock Performance Analysis

Loading Price Chart...

20MICRONS
CPL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
20 Microns Ltd.3.54%1.99%8.52%24.79%-1.97%-10.97%
Chemo-Pharma Laboratories Inc.0.43%-0.20%-9.72%10.04%-11.06%-12.31%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
20 Microns Ltd.-18.83%88.11%194.15%522.42%622.26%1,472.16%
Chemo-Pharma Laboratories Inc.-5.34%232.23%82.57%325.71%1,271.09%1,271.09%

Performance & Financial Health Analysis: 20 Microns Ltd. vs Chemo-Pharma Laboratories Inc.

Metric20MICRONSCPL
Market Information
Market Cap i₹6.38B₹4.62B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i193,48197,700
90 Day Avg. Volume i147,51268,661
Last Close₹188.82₹70.50
52 Week Range₹129.61 - ₹283.93₹52.67 - ₹87.75
% from 52W High-33.50%-19.66%
All-Time High₹348.00 (Aug 19, 2024)₹128.00 (Jan 06, 2025)
% from All-Time High-45.74%-44.92%
Growth Metrics
Quarterly Revenue Growth0.00%0.40%
Quarterly Earnings Growth0.16%0.41%
Financial Health
Profit Margin (TTM) i0.07%0.07%
Operating Margin (TTM) i0.11%0.12%
Return on Equity (TTM) i0.14%0.21%
Debt to Equity (MRQ) i35.6448.02
Cash & Liquidity
Book Value per Share (MRQ)₹128.71₹28.58
Cash per Share (MRQ)₹16.54₹0.05
Operating Cash Flow (TTM) i₹271.62M₹277.99M
Levered Free Cash Flow (TTM) i₹623.76M₹313.23M
Dividends
Last 12-Month Dividend Yield i0.45%N/A
Last 12-Month Dividend i₹1.25₹0.00

Valuation & Enterprise Metrics Analysis: 20 Microns Ltd. vs Chemo-Pharma Laboratories Inc.

Metric20MICRONS (Apr 24, 2026)CPL (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i9.7613.22
Forward P/E iN/AN/A
PEG Ratio i0.600.42
Price to Sales (TTM) i0.681.31
Price to Book (MRQ) i1.392.69
Market Capitalization
Market Capitalization i₹6.38B₹4.62B
Enterprise Value i₹7.38B₹5.40B
Enterprise Value Metrics
Enterprise to Revenue i0.801.52
Enterprise to EBITDA i6.2913.60
Risk & Other Metrics
Beta i0.550.28
Book Value per Share (MRQ) i₹128.71₹28.58

Financial Statements Comparison: 20 Microns Ltd. vs Chemo-Pharma Laboratories Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

Metric20MICRONS (2025)CPL (2025)
Revenue/Sales i9.12B2.85B
Cost of Goods Sold i5.85B2.07B
COGS % of Revenue i64.1%72.6%
Gross Profit i3.27B778.98M
Gross Margin i35.9%27.4%
Research & Development iN/AN/A
Operating Income (EBIT) i1.01B300.69M
Operating Margin i11.0%10.6%
EBITDA i1.14B353.29M
EBITDA Margin i12.5%12.4%
Pre-Tax Income i826.98M392.47M
Pre-Tax Income % of Revenue i9.1%13.8%
Income Tax i202.13M79.24M
Income Tax % of Revenue i2.2%2.8%
Net Income (Profit) i624.85M313.23M
Profit Margin i6.9%11.0%

Balance Sheet & Liquidity Metrics

Metric20MICRONS (2025)CPL (2025)
Cash & Equivalents i312.98M12.05M
Total Current Assets i3.75B2.51B
Total Current Assets % of Revenue i41.2%88.1%
Total Current Liabilities i2.19B1.17B
Total Current Liabilities % of Revenue i24.1%41.2%
Long-Term Debt i321.53M109.50M
Long-Term Debt % of Revenue i3.5%3.8%
Total Shareholders Equity i4.34B1.49B
Retained Earnings i3.39B1.08B
Retained Earnings % of Revenue i37.2%37.9%
Property, Plant & Equipment i254.97M48.61M

Cash Flow Statement Comparison

Metric20MICRONS (2025)CPL (2025)
Operating Cash Flow i271.62M277.99M
Operating Cash Flow % of Revenue i3.0%9.8%
Capital Expenditures i-753.18M-47.82M
Free Cash Flow i-448.94M41.66M
FCF Margin i-4.9%1.5%
Debt Repayment iN/A-359.80M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

Metric20MICRONSCPL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i35.29M60.18M
Float Shares i14.45M17.41M
% Held by Insiders i55.05%69.98%
% Held by Institutions i0.02%0.00%
% Held by Public i44.93%30.02%

Dividend Analysis & Yield Comparison: 20 Microns Ltd. vs Chemo-Pharma Laboratories Inc.

Metric20MICRONSCPL
Last 12-Month Dividend i₹1.25₹0.00
Last 12-Month Dividend Yield i0.45%N/A
3-Year Avg Annual Dividend i₹1.08₹0.00
3-Year Avg Dividend Yield i0.56%N/A
3-Year Total Dividends i₹3.25₹0.00
Ex-Dividend DateJul 24, 2025N/A